Glucose Homeostasis and Shared Genetic Factors in Colorectal Cancer
NCT07648589 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-06-15
Summary
Colorectal cancer (CRC) and diabetes mellitus are two common diseases that frequently occur together and may share underlying genetic, metabolic, and immune-related mechanisms. Previous studies have shown that diabetes is associated with an increased risk of colorectal cancer and poorer clinical outcomes, while colorectal cancer itself may also influence glucose metabolism.
This prospective observational study aims to investigate the relationships among glucose homeostasis, shared genetic factors, inflammatory responses, immune cell profiles, and colorectal cancer outcomes. Participants with colorectal cancer and non-colorectal cancer controls will undergo serial assessments of glucose-related biomarkers, inflammatory markers, immune cell populations, and genetic analyses over time.
The study will focus on identifying shared genetic variants that may contribute to both colorectal cancer and diabetes-related traits, as well as exploring biological pathways involving inflammation, immune regulation, and metabolism. Blood samples and available colorectal tissue specimens will be analyzed to evaluate gene expression, immune cell distribution, and molecular changes associated with disease progression.
The results of this study may improve understanding of the biological links between colorectal cancer and diabetes, facilitate the development of personalized risk assessment strategies, and identify potential biomarkers and therapeutic targets for patients with colorectal cancer.
Conditions
- Colorectal Cancer
- Diabetes Mellitus
- Glucose Homeostasis
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-01
- Primary Completion
- 2028-05-30
- Completion
- 2029-05-30
More Related Trials
-
Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal Cancer
NCT02614339 ·Status: UNKNOWN ·Phase: PHASE3
-
Genomics and Prognosis in GI Cancers
NCT05767697 ·Status: RECRUITING
-
Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
NCT01632020 ·Status: TERMINATED ·Phase: PHASE2
-
Exploration of the Relationship Between Mismatch Repair Status of Colorectal Cancer and Lymph Node Metastasis Patterns and Pathological High-risk Factors
NCT06798857 ·Status: COMPLETED
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer:MetBio-CRC
NCT07068529 ·Status: RECRUITING
-
Mutational Profiling in Colorectal Tumors to Determine Its Role in the Diagnosis, Prognostic Significance and Their Impact in Clinical Management
NCT01371942 ·Status: UNKNOWN
-
Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases
NCT06477718 ·Status: COMPLETED
-
The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer
NCT03923335 ·Status: NOT_YET_RECRUITING
-
Metformin for the Prevention of CRA Recurrence
NCT04885426 ·Status: UNKNOWN ·Phase: NA
-
Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.
NCT02542670 ·Status: UNKNOWN
-
Are Sporadic Colorectal Cancers in Young Distinct From Elderly?
NCT05601609 ·Status: COMPLETED
-
Evaluation of Somatic Mutation Spectrum as Biomarker for Survival Outcome in Chinese CRC
NCT04228614 ·Status: UNKNOWN
-
Alcohol Intake, Alcohol Metabolizing Enzymes Gene Polymorphisms and the Risk of Colorectal Cancer
NCT03155542 ·Status: COMPLETED
-
Epiction of the Genomic and Genetic Landscape Identifies CCL5 as a Protective Factor in Colorectal Neuroendocrine Carcinoma
NCT05714722 ·Status: COMPLETED
-
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients
NCT02022995 ·Status: COMPLETED
-
Evaluation of Some Risk Factors Associated With Colorectal Cancer
NCT05170360 ·Status: UNKNOWN
-
Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages
NCT05445570 ·Status: COMPLETED
-
Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population
NCT04947930 ·Status: UNKNOWN
-
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC
NCT04912882 ·Status: NOT_YET_RECRUITING
-
Survival Outcomes by Tumor-Node Stage and Recurrence Patterns in Colon Cancer After Radical Surgery
NCT07167147 ·Status: COMPLETED
-
Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence
NCT06143644 ·Status: ACTIVE_NOT_RECRUITING
-
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
NCT06831669 ·Status: RECRUITING
-
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp
NCT05638542 ·Status: ACTIVE_NOT_RECRUITING
-
Next-generation Sequencing of Colorectal Cancer Somatic Cells to Guide Genetic Susceptibility Gene Mutations Screening.
NCT04280666 ·Status: UNKNOWN